rolipram has been researched along with Choriocarcinoma in 1 studies
Choriocarcinoma: A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rolipram is a selective phosphodiesterase-4 (PDE4) inhibitor." | 5.91 | Rolipram suppresses migration and invasion of human choriocarcinoma cells by inhibiting phosphodiesterase 4-mediated epithelial-mesenchymal transition. ( Huang, Y; Qi, C; Wang, Q; Zheng, Y, 2023) |
| "Rolipram is a selective phosphodiesterase-4 (PDE4) inhibitor." | 1.91 | Rolipram suppresses migration and invasion of human choriocarcinoma cells by inhibiting phosphodiesterase 4-mediated epithelial-mesenchymal transition. ( Huang, Y; Qi, C; Wang, Q; Zheng, Y, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y | 1 |
| Zheng, Y | 1 |
| Wang, Q | 1 |
| Qi, C | 1 |
1 other study available for rolipram and Choriocarcinoma
| Article | Year |
|---|---|
Rolipram suppresses migration and invasion of human choriocarcinoma cells by inhibiting phosphodiesterase 4-mediated epithelial-mesenchymal transition.
Topics: Cell Line, Tumor; Choriocarcinoma; Cyclic Nucleotide Phosphodiesterases, Type 4; Epithelial-Mesenchy | 2023 |